You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

AMCINONIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Amcinonide patents expire, and what generic alternatives are available?

Amcinonide is a drug marketed by Genus Lifesciences, Taro Pharm Inds, and Genus. and is included in five NDAs.

The generic ingredient in AMCINONIDE is amcinonide. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the amcinonide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Amcinonide

A generic version of AMCINONIDE was approved as amcinonide by TARO PHARM INDS on May 31st, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AMCINONIDE?
  • What are the global sales for AMCINONIDE?
  • What is Average Wholesale Price for AMCINONIDE?
Drug patent expirations by year for AMCINONIDE
Drug Prices for AMCINONIDE

See drug prices for AMCINONIDE

Pharmacology for AMCINONIDE

US Patents and Regulatory Information for AMCINONIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genus Lifesciences AMCINONIDE amcinonide CREAM;TOPICAL 076065-001 May 15, 2003 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Genus AMCINONIDE amcinonide OINTMENT;TOPICAL 076096-001 Nov 19, 2002 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Taro Pharm Inds AMCINONIDE amcinonide CREAM;TOPICAL 076229-001 May 31, 2002 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Genus AMCINONIDE amcinonide LOTION;TOPICAL 076329-001 Nov 6, 2002 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Taro Pharm Inds AMCINONIDE amcinonide OINTMENT;TOPICAL 076367-001 Mar 19, 2003 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.